Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Scorpio Bulkers Inc (SALT): Blue Mountain Capital Ups Stake

Is it a good time to buy Scorpio Bulkers Inc (NYSE:SALT) stock? Andrew Feldstein and Stephen Siderow, the managers of Blue Mountain Capital, seem to think so, having added 182,295 shares to their previous stake in the company. As reported in a recent filing with the Securities and Exchange Commission, Blue Mountain has upped its stake to 9.92 million shares, which gives it control over 7.1% of the Scorpio Bulkers Inc (NYSE:SALT)’s common stock.

Andrew Feldstein and Stephen Siderow

Among the hedge fund’s we track, Avenue Capital and its manager, Marc Lasry, hold the largest stake in Scorpio Bulkers Inc (NYSE:SALT). According to its latest 13F Filing, Avenue Capital holds a little over 10 million shares with an estimated value of $89.1 million. York Capital Management also holds a sizable investment in the company with its manager, James Dinan, having initiated a position during the second quarter of this year. York Capital reportedly holds 9.34 million shares valued at $83.1 million. Israel Englander is not so optimistic, though, and has dumped 20% of his stake in Scorpio Bulkers Inc (NYSE:SALT) during the same period of time. As a result, his fund, Millennium Management, is left with 3.17 million shares worth in excess of $28.2 million.

On September 10, Scorpio Bulkers Inc (NYSE:SALT) has announced plans to offer $35 million worth of senior unsecured notes due 2019. On September 11, the company issued a statement in which it announced an increase in size of the offering to $60 million worth of notes. The proceedings from the offering are to be used for installment payments due under the company’s newbuilding program and for general corporate purposes.

With a market cap of $1.1 billion, Scorpio Bulkers Inc (NYSE:SALT) is traded at a trialing Price to Earnings (P/E) ratio of 21.45 and does not pay dividends. For the second quarter of 2014, the company announced revenues of $13.18 million and a loss of $0.11 per share. For the current quarter, analysts expect revenues of $18.3 million and a similar loss per share.

Feldstein and Siderow still like Actavis plc (NYSE:ACT), having boosted their fund’s stake in the company by 62% during the second quarter. Blue Mountain Capital has reported ownership of approximately 914,200 shares, worth $203.9 million, in their latest 13F filing. Eastman Kodak Co.(NYSE:KODK) is another stock Feldstein and Siderow had increased exposure to during the quarter. Their fund now holds 7.46 million shares valued at $182 million.

Disclosure: none.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!